Insertion of metal cations into hybrid organometallic halide perovskite nanocrystals for enhanced stability: eco-friendly synthesis, lattice strain engineering, and defect chemistry studies.

In this work, we developed a facile and environmentally friendly synthesis strategy for large-scale preparation of Cr-doped hybrid organometallic halide perovskite nanocrystals. In the experiment, methylammonium lead bromide, CH3NH3PbBr3, was efficiently doped with Cr3+ cations by eco-friendly method at low temperatures to grow crystals via antisolvent-crystallization. The as-synthesized Cr3+ cation-doped perovskite nanocrystals displayed ∼45.45% decrease in the (100) phase intensity with an enhanced Bragg angle (2θ) of ∼15.01° compared to ∼14.92° of pristine perovskites while retaining their cubic (221/Pm-cm, ICSD no. 00-069-1350) crystalline phase of pristine perovskites. During synthesis, an eco-friendly solvent, ethanol, was utilized as an antisolvent to grow nanometer-sized rod-like crystals. However, Cr3+ cation-doped perovskite nanocrystals display a reduced crystallinity of ∼67% compared to pristine counterpart with ∼75% crystallinity with an improved contact angle of ∼72° against water in thin films. Besides, as-grown perovskite nanocrystals produced crystallite size of ∼48 nm and a full-width-at-half-maximum (FWHM) of ∼0.19° with an enhanced lattice-strain of ∼4.52 × 10-4 with a dislocation-density of ∼4.24 × 1014 lines per m2 compared to pristine perovskite nanocrystals, as extracted from the Williamson-Hall plots. The as-obtained stable perovskite materials might be promising light-harvesting candidates for optoelectronic applications in the future.

Green aspects of photocatalysts during corona pandemic: a promising role for the deactivation of COVID-19 virus.

The selection of a facile, eco-friendly, and effective methodology is the need of the hour for efficient curing of the COVID-19 virus in air, water, and many food products. Recently, semiconductor-based photocatalytic methodologies have provided promising, green, and sustainable approaches to battle against viral activation via the oxidative capabilities of various photocatalysts with excellent performance under moderate conditions and negligible by-products generation as well. Considering this, recent advances in photocatalysis for combating the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are inclusively highlighted. Starting from the origin to the introduction of the coronavirus, the significant potential of photocatalysis against viral prevention and -disinfection is discussed thoroughly. Various photocatalytic material-based systems including metal-oxides, metal-free and advanced 2D materials (MXenes, MOFs and COFs) are systematically examined to understand the mechanistic insights of virus-disinfection in the human body to fight against COVID-19 disease. Also, a roadmap toward sustainable solutions for ongoing COVID-19 contagion is also presented. Finally, the challenges in this field and future perspectives are comprehensively discussed involving the bottlenecks of current photocatalytic systems along with potential recommendations to deal with upcoming pandemic situations in the future.

Sustainable solutions for indoor pollution abatement during COVID phase: A critical study on current technologies & challenges.

The appearance of the contagious virus COVID-19, several revelations and environmental health experts punctually predicted the possibly disastrous public health complications of coexisting catching and airborne contamination-arbitrated disease. But much attention has been given on the outdoor-mediated interactions. Almost 3.8 million premature deaths occur every year globally due to the illness from indoor air pollution. Considering the human staying longer span indoors due to restricted human activities or work from home, the indoor air quality (IAQ) might show prominent role for individual health life. Currently, the Environmental Protection Agency (EPA) ensures no regulation of indoor airborne pollution. Herein, the paper underlines the common bases of indoor air pollution, poor IAQ, and impacts of the aerosolized airborne particles on the human health. In order to address these challenges and collective contagion events in indoor environment, several emerging control techniques and preventive sustainable solutions are suggested. By this, more innovations need to be investigated in future to measure the impact of indoor air pollution on individual health.

Development of Three-Dimensional Nickel-Cobalt Oxide Nanoflowers for Superior Photocatalytic Degradation of Food Colorant Dyes: Catalyst Properties and Reaction Kinetic Study.

In this work, we present three-dimensional flower-like nickel-cobalt oxide (F-NCO) nanosheets developed in a facile, eco-friendly hydrothermal route to apply as photocatalysts for food colorant Allura Red AC dye removal under light illumination. Using Brunauer-Emmett-Teller analysis, it was found that the F-NCO nanosheets displayed a surface area of ∼53.65 m2/g and a Barrett-Joyner-Halenda pore size of ∼14 nm, which was also confirmed by the calculated crystallite size of ∼15 nm using powder X-ray diffraction (XRD) analysis. From Williamson-Hall analysis of XRD spectra, F-NCO nanosheets revealed a crystal-lattice strain of ∼3.42 × 10-3 and a dislocation density of ∼4.397 × 1015 lines/m2 in the crystal structure. Transmission electron microscopy analysis revealed that F-NCO nanosheets accumulated to form flower-like nanostructures of <100 nm length with a d-spacing of ∼2.6 Å, which is attributed to the (311) crystallographic plane (α = γ = ß = 90°, a = b = c = 8.110 Å, JCPDS No. 00-020-0781) of the cubic phase. The F-NCO nanosheets exhibited an excellent photocatalytic efficiency of ∼94.75% in ∼10 min with sodium borohydride under UV light. The Langmuir-Hinshelwood model determined pseudo-first-order reaction kinetics of dye degradation using the ln[AtA0]versus time plot. The kinetic study produced a first-order rate constant (k) of ∼0.219 min-1, resulting in ∼3.16 min half-life (t1/2) for the F-NCO-catalyzed degradation reaction. Thus outstanding photocatalytic performance of F-NCO nanosheets would display their huge potential for organic-pollutant removal from water with exceptional recyclability for wide research applications in the future.

Exploring Rapid Photocatalytic Degradation of Organic Pollutants with Porous CuO Nanosheets: Synthesis, Dye Removal, and Kinetic Studies at Room Temperature.

In this work, we report the facile, environmentally friendly, room-temperature (RT) synthesis of porous CuO nanosheets and their application as a photocatalyst to degrade an organic pollutant/food dye using NaBH4 as the reducing agent in an aqueous medium. Ultrahigh-resolution field effect scanning electron microscopy images of CuO displayed a broken nanosheet-like (a length of ∼160 nm, a width of ∼65 nm) morphology, and the lattice strain was estimated to be ∼1.24 × 10-3 using the Williamson-Hall analysis of X-ray diffraction plots. Owing to the strong quantum size confinement effect, CuO nanosheets resulted in an optical energy band gap of ∼1.92 eV, measured using Tauc plots of the ultraviolet-visible (UV-vis) spectrum, resulting in excellent photocatalytic efficiency. The RT synthesized CuO catalyst showed a high Brunauer-Emmet-Teller surface area of 30.88 ± 0.2313 m2/g (a correlation coefficient of 0.99972) with an average Barrett-Joyner-Halenda pore size of ∼20.385 nm. The obtained porous CuO nanosheets exhibited a high crystallinity of 73.5% with a crystallite size of ∼12 nm and was applied as an efficient photocatalyst for degradation of the organic pollutant/food dye, Allura Red AC (AR) dye, as monitored by UV-vis spectrophotometric analysis and evidenced by a color change from red to colorless. From UV-vis spectra, CuO nanosheets exhibited an efficient and ultrafast photocatalytic degradation efficiency of ∼96.99% for the AR dye in an aqueous medium within 6 min at RT. According to the Langmuir-Hinshelwood model, photodegradation reaction kinetics followed a pseudo-first-order reaction with a rate constant of k = 0.524 min-1 and a half-life (t 1/2) of 2.5 min for AR dye degradation in the aqueous medium. The CuO nanosheets showed an outstanding recycling ability for AR degradation and would be highly favorable and an efficient catalyst due to the synergistic effect of high adsorption capability and photodegradation of the food dye.

Controlled Size Growth of Thermally Stable Organometallic Halide Perovskite Microrods: Synergistic Effect of Dual-Doping, Lattice Strain Engineering, Antisolvent Crystallization, and Band Gap Tuning Properties.

Organometallic halide perovskites, as the light-harvesting material, have been extensively used for cost-effective energy production in high-performance perovskite solar cells, despite their poor stability in the ambient atmosphere. In this work, methylammonium lead iodide, CH3NH3PbI3, perovskite was successfully doped with KMnO4 using antisolvent crystallization to develop micrometer-length perovskite microrods. Thus, the obtained KMnO4-doped perovskite microrods have exhibited sharp, narrow, and red-shifted photoluminescence band, as well as high lattice strain with improved thermal stability compared to undoped CH3NH3PbI3. During the synthesis of the KMnO4-doped perovskite microrods, a low boiling point solvent, anhydrous chloroform, was employed as an antisolvent to facilitate the emergence of controlled-size perovskite microrods. The as-synthesized KMnO4-doped perovskite microrods retained the pristine perovskite crystalline phases and lowered energy band gap (∼1.57 eV) because of improved light absorption and narrow fluorescence emission bands (fwhm < 10 nm) with improved lattice strain (∼4.42 × 10-5), Goldsmith tolerance factor (∼0.89), and high dislocation density (∼5.82 × 10-4), as estimated by Williamson-Hall plots. Thus, the obtained results might enhance the optical properties with reduced energy band gap and high thermal stability of doped-perovskite nanomaterials in ambient air for diverse optoelectronic applications. This study paves the way for new insights into chemical doping and interaction possibilities in methylamine-based perovskite materials with various metal dopants for further applications.

Postoperative pain relief with epidural buprenorphine versus epidural butorphanol in laparoscopic hysterectomies: A comparative study.

BACKGROUND: The purpose of this study was to compare the safety and efficacy of postoperative analgesia with epidural buprenorphine and butorphanol tartrate. METHODS: Sixty patients who were scheduled for elective laparoscopic hysterectomies were randomly enrolled in the study. At the end of the surgery, in study Group A 1 ml (0.3 mg) of buprenorphine and in Group B 1 ml (1 mg) of butorphanol tartrate both diluted to 10 ml with normal saline was injected through the epidural catheter. Visual analog pain scales (VAPSs) were assessed every hour till the 6(th) h, then 2(nd) hourly till the 12(th) h. To assess sedation, Ramsay sedation score was used. The total duration of postoperative analgesia was taken as the period from the time of giving epidural drug until the patients first complain of pain and the VAPS is more than 6. Patients were observed for any side effects such as respiratory depression, nausea, vomiting, hypotension, bradycardia, pruritus, and headache. RESULTS: Buprenorphine had a longer duration of analgesia when compared to butorphanol tartrate (586.17 ± 73.64 vs. 342.53 ± 47.42 [P < 0.001]). Nausea, vomiting (13% vs. 10%), and headache (20% vs. 13%) were more in buprenorphine group; however, sedation score and pruritus (3% vs. 6%) were found to be more with butorphanol. CONCLUSION: Epidural buprenorphine significantly reduced pain and increased the quality of analgesia with a longer duration of action and was a better alternative to butorphanol for postoperative pain relief.

Acetaminophen, phenacetin and dipyrone do not modulate pressor responses to arachidonic Acid or to pressor agents.

In contrast to nonsteroidal anti-inflammatory drugs (NSAIDs), the nonopioid analgesics phenacetin, acetaminophen and dipyrone exhibit weak anti-inflammatory properties. An explanation for this difference in pharmacologic activity was provided by the recent discovery of a new cyclooxygenase isoform, cyclooxygenase (COX)-3, that is reported to be inhibited by phenacetin, acetaminophen and dipyrone. However, COX-3 was found to be a spliced variant of COX-1 and renamed COX-1b. Although recent studies provide evidence for the existence of this new COX isoform, it is uncertain whether this COX-3 (COX-1b) isoform, or putative acetaminophen-sensitive pathway, plays a role in the generation of vasoactive prostaglandins. NSAIDs increase systemic blood pressure by inhibiting the formation of vasodilator prostanoids. Angiotensin II, norepinephrine and other vasoconstrictor agents have been reported to release prostaglandins. It is possible that this acetaminophen-sensitive pathway also modulates pressor responses to these vasoconstrictor agents. Therefore, the purpose of the present study was to determine whether this acetaminophen-sensitive pathway plays a role in the generation of vasoactive products of arachidonic acid or in the modulation of vasoconstrictor responses in the pulmonary and systemic vascular bed of the intact-chest rat. In the present study, the nonopioid analgesics did not attenuate changes in pulmonary or systemic arterial pressure in response to injections of the prostanoid precursor, arachidonic acid, to the thromboxane A(2) mimic, U46619, or to angiotensin II or norepinephrine. The results of the present study do not provide evidence in support of a role of a functional COX-3 (COX-1b) isoform, or an acetaminophen-sensitive pathway, in the generation of vasoactive prostanoids or in the modulation of responses to vasoconstrictor hormones in the intact-chest rat.

Differential effects of losartan and candesartan on vasoconstrictor responses in the rat.

Losartan has been reported to have inhibitory effects on thromboxane (TP) receptor-mediated responses. In the present study, the effects of 2 nonpeptide angiotensin II (AT1) receptor antagonists, losartan and candesartan, on responses to angiotensin II, the thromboxane A2 mimic, U46619, and norepinephrine were investigated and compared in the pulmonary and systemic vascular beds of the intact-chest rat. In this study, intravenous injections of angiotensin II, U46619, and norepinephrine produced dose-related increases in pulmonary and systemic arterial pressure. Losartan and candesartan, in the doses studied, decreased or abolished responses to angiotensin II. Losartan, but not candesartan, and only in a higher dose, produced small, but statistically significant, reductions in pressor responses to U46619 and to norepinephrine in the pulmonary and systemic vascular beds. Furthermore, losartan significantly reduced arachidonic acid-induced platelet aggregation, whereas candesartan had no effect. Pressor responses to angiotensin II were not changed by thromboxane and alpha-adrenergic receptor antagonists, or by cyclooxygenase and NO synthase inhibitors. These results show that losartan and candesartan are potent selective AT1 receptor antagonists in the pulmonary and systemic vascular beds and that losartan can attenuate thromboxane and alpha-adrenergic responses when administered at a high dose, whereas candesartan in the highest dose studied had no effect on responses to U46619 or to norepinephrine. The present data show that the effects of losartan and candesartan on vasoconstrictor responses are different and that pulmonary and systemic pressor responses to angiotensin II are not modulated or mediated by the release of cyclooxygenase products, activation of TP receptors, or the release of NO in the anesthetized rat.